2024/07/16 08:00:00 | |
---|---|
Price | |
6,600.00 JPY | |
Difference | -0.65% (-43.00) |
ISIN | JP3347200002 |
Symbol | 4507 |
Exchange | Tokyo Stock Exchange |
Currency | JPY |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,441 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 6,599.00 JPY (800) |
Ask (Ask size) | 6,609.00 JPY (100) |
Open | 6,642.00 JPY |
High | 6,671.00 JPY |
Low | 6,583.00 JPY |
Close (prev. day) | 6,643.00 JPY |
VWAP | 6,614.282 JPY |
Volume (pcs) | 955,800 |
Trading volume | 63,219,307.00 |
Number of trades | 2,525 |
Last size | 246,100 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings | ||
2024/05/29 | Global Equity Ratings | ||
2024/04/26 | Global Equity Ratings |
2024/07/16 08:00:00 | |
---|---|
Price | |
6,600.00 JPY | |
Difference | -0.65% (-43.00) |
ISIN | JP3347200002 |
Symbol | 4507 |
Exchange | Tokyo Stock Exchange |
Currency | JPY |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,441 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 6,599.00 JPY (800) |
Ask (Ask size) | 6,609.00 JPY (100) |
Open | 6,642.00 JPY |
High | 6,671.00 JPY |
Low | 6,583.00 JPY |
Close (prev. day) | 6,643.00 JPY |
VWAP | 6,614.282 JPY |
Volume (pcs) | 955,800 |
Trading volume | 63,219,307.00 |
Number of trades | 2,525 |
Last size | 246,100 |
6m | 1Y | 3Y | |
Perf (%) | -8.31% | +12.90% | +15.34% |
Perf (abs.) | -598.00 | +754.00 | +878.00 |
Beta | 0.46 | 0.50 | 0.62 |
Volatility | 28.98 | 24.04 | 28.52 |
Ø price 5 days | Ø volume 5 days (pcs.) | 6,598.75 JPY (1,218,880) |
Ø price 30 days | Ø volume 30 days (pcs.) | 6,314.83 JPY (1,800,287) |
Ø price 100 days | Ø volume 100 days (pcs.) | 7,097.46 JPY (1,272,871) |
Ø price 250 days | Ø volume 250 days (pcs.) | 6,879.90 JPY (1,218,282) |
YTD High | date | 8,137.00 JPY (2024/03/07) |
YTD Low | date | 5,980.00 JPY (2024/06/24) |
52 Weeks High | date | 8,137.00 JPY (2024/03/07) |
52 Weeks Low | date | 5,785.00 JPY (2023/07/18) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/07/16 | 22:26 | 38.60 EUR | 0.00 | 1 |
Tokyo Stock Exchange | 2024/07/16 | 08:00 | 6,600.00 JPY | 63.22 | 2,525 |
Stuttgart | 2024/07/16 | 08:03 | 37.60 EUR | 0.00 | 3 |
Munich | 2024/07/16 | 08:00 | 37.60 EUR | 0.00 | 1 |
Frankfurt | 2024/07/16 | 21:50 | 37.80 EUR | 0.00 | 3 |
FINRA other OTC Issues | 2024/07/15 | 17:51 | 42.07 USD | 0.01 | 2 |
Duesseldorf | 2024/07/16 | 19:31 | 37.40 EUR | 0.00 | 6 |
Berlin | 2024/07/16 | 08:29 | 38.00 EUR | 0.00 | 1 |
SHIONOGI & CO. LTD. |
- - |
3-1-8 Dosho-machi, Chuo-Ku - 541-0045 Osaka |
Telefon: +81-6-6202-2161 |
Fax: +81-6-6229-9596 |
E-mail: - |
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan. |
Ph.D. Isao Teshirogi | Chairman of Managing Board |
John Keller | Member of Executive Committee |
Kazuhiro Hatanaka | Member of Executive Committee |
Kohji Hanasaki | Member of Executive Committee |
Noriyuki Kishida | Member of Executive Committee |
Ryuichi Kiyama | Member of Executive Committee |
Toshinobu Iwasaki | Member of Executive Committee |
Yasuyoshi Isou | Member of Executive Committee |
Fumi Takatsuki | Member of Supervisory Board |
Hiroshi Ozaki | Member of Supervisory Board |
Keiichi Ando | Member of Supervisory Board |
Takuko Sawada | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer